DrugPatentWatch Database Preview
Onyx Therap Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ONYX THERAP, and when can generic versions of ONYX THERAP drugs launch?
ONYX THERAP has one approved drug.
There are eleven US patents protecting ONYX THERAP drugs.
There are one hundred and eighty-eight patent family members on ONYX THERAP drugs in forty countries and fifteen supplementary protection certificates in thirteen countries.
Summary for Onyx Therap
| International Patents: | 188 |
| US Patents: | 11 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Onyx Therap: | See patent lawsuits for Onyx Therap |
Drugs and US Patents for Onyx Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onyx Therap | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-001 | Jul 20, 2012 | AP | RX | Yes | Yes | 7,417,042 | Start Trial | Y | Y | Start Trial | |
| Onyx Therap | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-002 | Jun 3, 2016 | AP | RX | Yes | No | 8,207,126 | Start Trial | Y | Start Trial | ||
| Onyx Therap | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-001 | Jul 20, 2012 | AP | RX | Yes | Yes | 8,207,297 | Start Trial | Y | Y | Start Trial | |
| Onyx Therap | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-001 | Jul 20, 2012 | AP | RX | Yes | Yes | 9,511,109 | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ONYX THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | For Injection | 10 mg/vial | ➤ Subscribe | 2018-11-28 |
| ➤ Subscribe | For Injection | 60 mg/vial | ➤ Subscribe | 2016-07-20 |
International Patents for Onyx Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2549763 | Start Trial |
| Tunisia | 2011000200 | Start Trial |
| Australia | 2009308516 | Start Trial |
| Portugal | 3101026 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Onyx Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1781688 | 16C0017 | France | Start Trial | PRODUCT NAME: CARFILZOMIB; REGISTRATION NO/DATE: EU/1/15/1060 20151123 |
| 1781688 | 300805 | Netherlands | Start Trial | PRODUCT NAME: CARFILZOMIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/15/1060 20151123 |
| 1781688 | 2016/013 | Ireland | Start Trial | PRODUCT NAME: CARFILZOMIB OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTRATION NO/DATE: EU/1/15/1060 20151119 |
| 1781688 | 132016000047656 | Italy | Start Trial | PRODUCT NAME: CARFILZOMIB OPZIONALMENTE IN FORMA DI UN SALE FARMACEUTICAMENTE ACCETTABILE(KYPROLIS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1060, 20151123 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
